Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
GSK2981278 is an inverse agonist of retinoic acid receptor-related nuclear receptor γ (RORγ; IC50 = 17 nM in a transactivation assay).1 It is selective for RORγ over RORα.2 GSK2981278 inhibits IL-17A and IL-22 protein secretion from isolated human peripheral blood T cells grown under Th17 skewing conditions (IC50 = 3.2 nM). Topical application of GSK2981278 (1% ointment) reduces dermal symptoms in a mouse model of psoriasis induced by imiquimod (Item No. 14956).
WARNING This product is not for human or veterinary use.
1. Sulfoximines as potent RORγ inverse agonists. Bioorg. Med. Chem. Lett. 28(8), 1269-1273 (2018).
2. Development of a topical treatment for psoriasis targeting RORγ: From bench to skin. PLoS One 11(2), e0147979 (2016).